Cargando…
534. The Use of Tocilizumab and Remdesivir in SARS- CoV-2 Patients in El Paso Texas: A Longitudinal Comparative Observational Study
BACKGROUND: Currently, the management of SARS-CoV-2 varies with no definitive clinical guidelines, as scientific evidence across the globe differs in therapeutic options. This study intends to provide some clarity to the insufficient data based on the role of monotherapy with tocilizumab (TCZ) and c...
Autores principales: | Almaghlouth, Nouf K, Anyiam, Felix, Attia, Mohamed, Robinson, Matthew, Shah, Sidra, Haq, Syed, Guevara, Roberto, Antony, Suresh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690746/ http://dx.doi.org/10.1093/ofid/ofab466.733 |
Ejemplares similares
-
The Use of Single Therapy With Tocilizumab Versus Combination Therapy With Remdesivir and Tocilizumab in SARS-CoV-2 Patients in El Paso, Texas
por: Almaghlouth, Nouf K, et al.
Publicado: (2021) -
682. Is There a Role for the Early Use of Tocilizumab and Interleukin-6 Levels in the Management of SARS-CoV-2 Patients with Early Respiratory Failure?
por: Antony, Suresh J, et al.
Publicado: (2020) -
171. Gram-Positive Blood Culture Contamination Rates: A Comparative Assessment Between Verigene® and Conventional Method
por: Almaghlouth, Nouf K, et al.
Publicado: (2023) -
Contrasting Birth Preferences to Practices in El Paso, Texas
por: Curtis, Rachel S., et al.
Publicado: (2022) -
Social Disparities in Children’s Respiratory Health in El Paso, Texas
por: Grineski, Sara E., et al.
Publicado: (2014)